A cancer diagnosis changes everything. And for many people in the UK, the treatment itself brings a second wave of challenges that can feel as difficult to manage as the disease. Persistent pain, relentless nausea, nights without sleep, a body that won’t eat, and a mind that won’t settle. Standard supportive care addresses some of this. However, for a growing number of patients, it does not address enough.
Key Takeaways:
- Around 346,000 new cancer cases were diagnosed in England in 2022, with the majority of patients experiencing multiple treatment-related symptoms simultaneously.
- Medical cannabis has been prescribed fewer than five times via the NHS since its legalisation in 2018. Most patients access it through specialist private clinics following a full clinical assessment.
- The five areas with the most relevant evidence for cancer patients are: pain, chemotherapy-induced nausea and vomiting, sleep disruption, appetite loss, and anxiety.
- Medical cannabis is a complementary option for patients whose symptoms remain inadequately controlled; it is not a replacement for oncology care or prescribed anti-cancer treatment.
- A specialist clinical assessment is required before any cannabis-based medicine can be prescribed. Your oncology team should always be informed.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, nor does it replace a consultation with a qualified clinician. Medical cannabis is not a first-line treatment for cancer or cancer-related symptoms and must never replace oncology care, palliative treatment, or prescribed anti-cancer therapies. Cannabis-based medicines may interact with chemotherapy agents, immunosuppressants, and other oncology medications. Always inform your oncologist and prescribing clinician of all treatments before starting anything new. Whether medical cannabis is appropriate for your individual circumstances can only be determined following a full clinical assessment with a GMC-registered specialist. To find out whether you may be eligible, visit leafease.co.uk.
Five Ways Medical Cannabis May Support Quality of Life
1. Pain Management
Cancer pain is one of the most common and most undertreated symptoms in oncology. It can arise from the tumour itself, from nerve damage, from surgery, or from treatment. For patients whose pain is not adequately controlled by standard analgesia, including opioids, cannabis-based medicines have been explored as an adjunctive option.
The most substantial UK evidence comes from the UK Medical Cannabis Registry, in a 2025 study where the case series followed 168 cancer pain patients prescribed CBMPs at specialist clinics. Across all pain-specific patient-reported outcome measures, pain intensity, pain interference, and overall pain-related quality of life, improvements were observed at one, three, and six months. Crucially, no life-threatening adverse events were reported, and most adverse events recorded were mild to moderate. [1]
2. Chemotherapy-Induced Nausea and Vomiting (CINV)
Waking up with a bitter, metallic taste coating your mouth that no amount of water shifts. The smell of toast is enough to send you back to bed. By mid-morning the nausea has settled into relentless. Of all the symptom areas where cannabis-based medicines have been studied in cancer patients, chemotherapy-induced nausea and vomiting has the deepest evidence base. The cannabinoid medicine Nabilone is already licensed in the UK and approved by NICE for use as a third-line antiemetic when first- and second-line treatments have failed to provide adequate control. [2]
A 2025 systematic review found that cannabinoids had superior overall CINV control compared to placebo with a relative risk of 2.65, meaning patients were more than twice as likely to achieve complete nausea and vomiting control. [3]
3. Sleep Disruption
Sleep problems during cancer treatment are extremely common and frequently underreported. A 2024 UK Medical Cannabis Registry study on insomnia patients, showed that CBMPs were associated with statistically significant improvements in single-item sleep quality scores over six months. [4] Cannabis-based medicines have been associated with improvements in sleep quality in the UK Medical Cannabis Registry’s cancer pain cohort, where sleep scores improved significantly at one, three, and six months alongside pain outcomes. [1]
4. Appetite Loss and Cachexia
Loss of appetite during cancer treatment is not simply a matter of not feeling hungry. Cancer-related cachexia, a syndrome involving progressive muscle loss and metabolic disruption affects an estimated 50 to 80% of cancer patients and is directly associated with worse treatment outcomes and reduced survival. [5] For many patients, maintaining adequate nutrition during chemotherapy is one of the most practically difficult aspects of treatment.
Cannabinoids’ appetite-stimulating properties are among the best-known potential benefits of cannabis-based medicines. THC acts on CB1 receptors in the hypothalamus to stimulate appetite signals, and this effect has been observed in multiple patient populations. A 2025 meta-analysis published in Cannabis and Cannabinoid Research, found that support for medical cannabis in improving appetite was the strongest of any symptom domain examined, with studies more than twice as likely to report positive outcomes on appetite than not. [6]
5. Anxiety and Psychological Distress
A cancer diagnosis carries a psychological weight that oncology services are not always structured to address fully. Anxiety and depression are common during treatment, the evidence for cannabis-based medicines specifically in cancer-related anxiety is nuanced. The UK Medical Cannabis Registry’s cancer pain cohort showed statistically significant improvements in GAD-7 anxiety scores at one, three, and six months, alongside improvements in pain and sleep. [1] This matters clinically: when pain is better controlled and sleep improves, anxiety frequently follows. The relationship is bidirectional. Anxiety worsens pain perception. Disrupted sleep worsens anxiety. A treatment that meaningfully addresses pain and sleep may, in turn, reduce anxiety.
Medical Cannabis in Cancer Treatment: When Standard Supportive Care Falls Short
Consider a woman in her early sixties, two months into her third cycle of chemotherapy for ovarian cancer. Her antiemetics are partially effective but she still experiences waves of nausea on days two and three post-infusion that make eating impossible. She is sleeping poorly, waking frequently from a combination of pain and anxiety. Her appetite has been diminished for weeks; she has lost four kilograms in the last month.
This is the type of clinical picture that UK specialist prescribers see when considering whether cannabis-based medicines may have a role. The goal in this context is not to treat the cancer. It is to make the treatment more bearable and to help a patient eat, sleep, and manage pain well enough to continue with the treatment their oncologist has recommended. However, since its legalisation in the UK in November 2018, medical cannabis have been prescribed fewer than five times via the NHS. [7] For most cancer patients, access means a specialist private clinic.
One concern raised repeatedly by cancer patients considering medical cannabis is the fear of waking up mentally foggy. For someone already managing fatigue from chemotherapy, it is a reasonable concern, and one your LeafEase clinician takes seriously.
Formulation is the answer. CBD-dominant and lower-THC products carry far less risk of next-day sedation than high-THC preparations. If it is not the right balance, the prescription is adjusted. This is not a fixed protocol, it is ongoing clinical management with continuity built in. The specialist who conducts your initial assessment remains your prescriber. They review your oncology background, current medications, daily routine, and your goals. Follow-up consultations are built into the LeafEase Advantage subscription, alongside free home delivery in discreet, unmarked packaging.
If you are going through cancer treatment and your current supportive care is leaving gaps, check your eligibility with LeafEase in a few minutes. A video consultation with a GMC-registered specialist can be arranged without a GP referral.
Frequently Asked Questions
Can I access medical cannabis for cancer symptoms on the NHS?
Nabilone, a synthetic cannabinoid, is licensed and available on the NHS for chemotherapy-induced nausea and vomiting as a third-line antiemetic. However, whole-plant cannabis-based medicinal products have been prescribed fewer than five times via the NHS since legalisation in 2018. For most patients, access to CBMPs means going through a specialist private clinic. A GP referral is not required for a LeafEase consultation.
Will medical cannabis interfere with my chemotherapy?
This is an important and clinically critical question. Some cannabinoids are metabolised through CYP450 liver enzymes, which are also involved in the metabolism of several chemotherapy agents. This means interactions are possible and must be assessed individually. Your LeafEase clinician will review your full oncology medication list before making any recommendation. You should also inform your oncologist that you are seeking a cannabis prescription.
Is medical cannabis safe during active cancer treatment?
The UK Medical Cannabis Registry data suggest that CBMPs can be prescribed with a relatively low incidence of adverse events in cancer patients, with no life-threatening events reported in the largest published case series. However, safety must be assessed individually. Dosing, formulation, route of administration, and the patient’s wider clinical picture all affect the risk-benefit profile.
I am exhausted enough from treatment. Will cannabis make my fatigue worse?
This depends entirely on formulation. High-THC products can cause sedation. CBD-dominant products, or lower-THC formulations taken at the right time of day, are far less likely to compound fatigue. Discussing your daily schedule and energy levels with your LeafEase clinician allows the prescription to be structured around your routine rather than disrupting it.
Can medical cannabis help with palliative care?
CBMPs have been prescribed in palliative care contexts in the UK, with some evidence of benefit for pain, sleep, and quality of life from UK Medical Cannabis Registry data. The goal in palliative care is comfort and quality of life. A LeafEase specialist can discuss whether cannabis-based medicines may play a role in supporting that goal based on individual clinical circumstances.
References
[1] Varadpande, M., Erridge, S., Aggarwal, A. et al. (2025). UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for cancer pain. Journal of Pain and Palliative Care Pharmacotherapy. Available at: https://pubmed.ncbi.nlm.nih.gov/39921589/ [Accessed: 5 June 2026].
[2] NICE. (2023). Nabilone for nausea and vomiting caused by chemotherapy. Available at: https://bnf.nice.org.uk/drugs/nabilone/ [Accessed: 5 June 2026].
[3] Chow, R., Basu, A., Kaur, J. et al. (2025). Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting, a systematic review and meta-analysis. Supportive Care in Cancer. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11828838/ [Accessed: 5 June 2026].
[4] Erridge, S., Sodergren, M.H. et al. (2024). UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia. Brain and Behavior, 14(2), e3410. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10858318/ [Accessed: 5 June 2026].
[5] Argilés, J.M., Busquets, S., Stemmler, B. and López-Soriano, F.J. (2014). Cancer cachexia: understanding the molecular basis. Nature Reviews Cancer, 14(11), pp.754–762. Available at: https://pubmed.ncbi.nlm.nih.gov/25291291/ [Accessed: 5 June 2026].
[6] Mead, A. et al. (2025). Meta-analysis of medical cannabis outcomes and associations with cancer. Cannabis and Cannabinoid Research. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12037605/ [Accessed: 5 June 2026].
[7] BBC News. (2023). Medicinal cannabis user calls for more NHS prescriptions. Available at: https://www.bbc.co.uk/news/uk-england-dorset-66808959 [Accessed: 5 June 2026].
